Sabatolimab
novartis
['mds', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
#eha22 #mdssm wiseman: summary of treatment approaches emerging in mds and a (elegant, but still very) theoretical tx algorithm that will be differentd by spec mutational profiles, allowing personalization of treatment for hr-mds pts. (nb: some hr-mds may be better txd as aml.) 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)